The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Glucose Testing-Global Market Insights and Sales Trends 2024
Synopsis
A blood glucose test measures the amount of glucose in your blood. Glucose, a type of simple sugar, is your body's main source of energy. Your body converts the carbohydrates you eat into glucose.
The global Glucose Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Glucose Testing in various end use industries. The expanding demands from the Diagnostic Centers/Clinics and Hospitals, are propelling Glucose Testing market. Minimal Invasive Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-invasive Testing segment is estimated at % CAGR for the next seven-year period.
In recent times there is increased use of glucose testing due to increasing aging population. Increasing obese population, increasing lifestyle associated diseases and increasing prevalence of diabetes are some of the key factors driving the growth for the U.S. glucose testing market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glucose Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glucose Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glucose Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glucose Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glucose Testing covered in this report include Johnson & Johnso, Roche Diagnostics, Bayer, Siemens, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Medtronic and B. Braun Melsungen, etc.
The global Glucose Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnso
Roche Diagnostics
Bayer
Siemens
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Medtronic
B. Braun Melsungen
Echo therapeutics
AgaMatrix
Arkay
Becton Dickinson
F. Hoffmann-La Roche
LifeScan
Novel Biomedical
Terumo
Global Glucose Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glucose Testing market, Segment by Type:
Minimal Invasive Testing
Non-invasive Testing
Global Glucose Testing market, by Application
Diagnostic Centers/Clinics
Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glucose Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
A blood glucose test measures the amount of glucose in your blood. Glucose, a type of simple sugar, is your body's main source of energy. Your body converts the carbohydrates you eat into glucose.
The global Glucose Testing market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Glucose Testing in various end use industries. The expanding demands from the Diagnostic Centers/Clinics and Hospitals, are propelling Glucose Testing market. Minimal Invasive Testing, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Non-invasive Testing segment is estimated at % CAGR for the next seven-year period.
In recent times there is increased use of glucose testing due to increasing aging population. Increasing obese population, increasing lifestyle associated diseases and increasing prevalence of diabetes are some of the key factors driving the growth for the U.S. glucose testing market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Glucose Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Glucose Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Glucose Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Glucose Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Glucose Testing covered in this report include Johnson & Johnso, Roche Diagnostics, Bayer, Siemens, Abbott Laboratories, Beckman Coulter, Bio-Rad Laboratories, Medtronic and B. Braun Melsungen, etc.
The global Glucose Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Johnson & Johnso
Roche Diagnostics
Bayer
Siemens
Abbott Laboratories
Beckman Coulter
Bio-Rad Laboratories
Medtronic
B. Braun Melsungen
Echo therapeutics
AgaMatrix
Arkay
Becton Dickinson
F. Hoffmann-La Roche
LifeScan
Novel Biomedical
Terumo
Global Glucose Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Glucose Testing market, Segment by Type:
Minimal Invasive Testing
Non-invasive Testing
Global Glucose Testing market, by Application
Diagnostic Centers/Clinics
Hospitals
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Glucose Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Glucose Testing
1.1 Glucose Testing Market Overview
1.1.1 Glucose Testing Product Scope
1.1.2 Glucose Testing Market Status and Outlook
1.2 Global Glucose Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Glucose Testing Market Size by Region (2018-2029)
1.4 Global Glucose Testing Historic Market Size by Region (2018-2023)
1.5 Global Glucose Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Glucose Testing Market Size (2018-2029)
1.6.1 North America Glucose Testing Market Size (2018-2029)
1.6.2 Europe Glucose Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Glucose Testing Market Size (2018-2029)
1.6.4 Latin America Glucose Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Glucose Testing Market Size (2018-2029)
2 Glucose Testing Market by Type
2.1 Introduction
2.1.1 Minimal Invasive Testing
2.1.2 Non-invasive Testing
2.2 Global Glucose Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Glucose Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Glucose Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Glucose Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Glucose Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Glucose Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Glucose Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Glucose Testing Revenue Breakdown by Type (2018-2029)
3 Glucose Testing Market Overview by Application
3.1 Introduction
3.1.1 Diagnostic Centers/Clinics
3.1.2 Hospitals
3.2 Global Glucose Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Glucose Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Glucose Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Glucose Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Glucose Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Glucose Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Glucose Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Glucose Testing Revenue Breakdown by Application (2018-2029)
4 Glucose Testing Competition Analysis by Players
4.1 Global Glucose Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Glucose Testing as of 2022)
4.3 Date of Key Players Enter into Glucose Testing Market
4.4 Global Top Players Glucose Testing Headquarters and Area Served
4.5 Key Players Glucose Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Glucose Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Johnson & Johnso
5.1.1 Johnson & Johnso Profile
5.1.2 Johnson & Johnso Main Business
5.1.3 Johnson & Johnso Glucose Testing Products, Services and Solutions
5.1.4 Johnson & Johnso Glucose Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Johnson & Johnso Recent Developments
5.2 Roche Diagnostics
5.2.1 Roche Diagnostics Profile
5.2.2 Roche Diagnostics Main Business
5.2.3 Roche Diagnostics Glucose Testing Products, Services and Solutions
5.2.4 Roche Diagnostics Glucose Testing Revenue (US$ Million) & (2018-2023)
5.2.5 Roche Diagnostics Recent Developments
5.3 Bayer
5.3.1 Bayer Profile
5.3.2 Bayer Main Business
5.3.3 Bayer Glucose Testing Products, Services and Solutions
5.3.4 Bayer Glucose Testing Revenue (US$ Million) & (2018-2023)
5.3.5 Siemens Recent Developments
5.4 Siemens
5.4.1 Siemens Profile
5.4.2 Siemens Main Business
5.4.3 Siemens Glucose Testing Products, Services and Solutions
5.4.4 Siemens Glucose Testing Revenue (US$ Million) & (2018-2023)
5.4.5 Siemens Recent Developments
5.5 Abbott Laboratories
5.5.1 Abbott Laboratories Profile
5.5.2 Abbott Laboratories Main Business
5.5.3 Abbott Laboratories Glucose Testing Products, Services and Solutions
5.5.4 Abbott Laboratories Glucose Testing Revenue (US$ Million) & (2018-2023)
5.5.5 Abbott Laboratories Recent Developments
5.6 Beckman Coulter
5.6.1 Beckman Coulter Profile
5.6.2 Beckman Coulter Main Business
5.6.3 Beckman Coulter Glucose Testing Products, Services and Solutions
5.6.4 Beckman Coulter Glucose Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Beckman Coulter Recent Developments
5.7 Bio-Rad Laboratories
5.7.1 Bio-Rad Laboratories Profile
5.7.2 Bio-Rad Laboratories Main Business
5.7.3 Bio-Rad Laboratories Glucose Testing Products, Services and Solutions
5.7.4 Bio-Rad Laboratories Glucose Testing Revenue (US$ Million) & (2018-2023)
5.7.5 Bio-Rad Laboratories Recent Developments
5.8 Medtronic
5.8.1 Medtronic Profile
5.8.2 Medtronic Main Business
5.8.3 Medtronic Glucose Testing Products, Services and Solutions
5.8.4 Medtronic Glucose Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Medtronic Recent Developments
5.9 B. Braun Melsungen
5.9.1 B. Braun Melsungen Profile
5.9.2 B. Braun Melsungen Main Business
5.9.3 B. Braun Melsungen Glucose Testing Products, Services and Solutions
5.9.4 B. Braun Melsungen Glucose Testing Revenue (US$ Million) & (2018-2023)
5.9.5 B. Braun Melsungen Recent Developments
5.10 Echo therapeutics
5.10.1 Echo therapeutics Profile
5.10.2 Echo therapeutics Main Business
5.10.3 Echo therapeutics Glucose Testing Products, Services and Solutions
5.10.4 Echo therapeutics Glucose Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Echo therapeutics Recent Developments
5.11 AgaMatrix
5.11.1 AgaMatrix Profile
5.11.2 AgaMatrix Main Business
5.11.3 AgaMatrix Glucose Testing Products, Services and Solutions
5.11.4 AgaMatrix Glucose Testing Revenue (US$ Million) & (2018-2023)
5.11.5 AgaMatrix Recent Developments
5.12 Arkay
5.12.1 Arkay Profile
5.12.2 Arkay Main Business
5.12.3 Arkay Glucose Testing Products, Services and Solutions
5.12.4 Arkay Glucose Testing Revenue (US$ Million) & (2018-2023)
5.12.5 Arkay Recent Developments
5.13 Becton Dickinson
5.13.1 Becton Dickinson Profile
5.13.2 Becton Dickinson Main Business
5.13.3 Becton Dickinson Glucose Testing Products, Services and Solutions
5.13.4 Becton Dickinson Glucose Testing Revenue (US$ Million) & (2018-2023)
5.13.5 Becton Dickinson Recent Developments
5.14 F. Hoffmann-La Roche
5.14.1 F. Hoffmann-La Roche Profile
5.14.2 F. Hoffmann-La Roche Main Business
5.14.3 F. Hoffmann-La Roche Glucose Testing Products, Services and Solutions
5.14.4 F. Hoffmann-La Roche Glucose Testing Revenue (US$ Million) & (2018-2023)
5.14.5 F. Hoffmann-La Roche Recent Developments
5.15 LifeScan
5.15.1 LifeScan Profile
5.15.2 LifeScan Main Business
5.15.3 LifeScan Glucose Testing Products, Services and Solutions
5.15.4 LifeScan Glucose Testing Revenue (US$ Million) & (2018-2023)
5.15.5 LifeScan Recent Developments
5.16 Novel Biomedical
5.16.1 Novel Biomedical Profile
5.16.2 Novel Biomedical Main Business
5.16.3 Novel Biomedical Glucose Testing Products, Services and Solutions
5.16.4 Novel Biomedical Glucose Testing Revenue (US$ Million) & (2018-2023)
5.16.5 Novel Biomedical Recent Developments
5.17 Terumo
5.17.1 Terumo Profile
5.17.2 Terumo Main Business
5.17.3 Terumo Glucose Testing Products, Services and Solutions
5.17.4 Terumo Glucose Testing Revenue (US$ Million) & (2018-2023)
5.17.5 Terumo Recent Developments
6 North America
6.1 North America Glucose Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Glucose Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Glucose Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Glucose Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Glucose Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Glucose Testing Market Dynamics
11.1 Glucose Testing Industry Trends
11.2 Glucose Testing Market Drivers
11.3 Glucose Testing Market Challenges
11.4 Glucose Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
